<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Improving Logical Changeover Production Readiness in the Life Sciences</title><link>/industries/lifesciences/b/life-sciences-blog/posts/improving-logical-changeover-production-readiness-in-the-life-sciences</link><description>Pharmaceutical and biopharmaceutical manufacturers have long felt the pressures of moving products from discovery to delivery as fast as they can—even given the highly regulated industry in which they operate. 
 Technology has continued to advance and</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>